More Important Ivermectin Study Results
Click here for more details on the map above
By Robert W Malone MD, MS | February 6, 2022
Research Gate, February 2022 DOI:10.13140/RG.2.2.20069.68320
This important preprint needs to hit alternative and mainstream media now.
The Study:
Background: Previously, we demonstrated that ivermectin use as prophylaxis for COVID-19 was associated with reductions in COVID-19 infection, hospitalization, and mortality rates, and in the risk of dying from COVID-19, irrespective of regularity and accumulated use of ivermectin, in an observational, prospectively obtained data from a strictly controlled city-wide program in a city in Southern Brazil (Itajaí, SC, Brazil) of of medically-based, optional use of ivermectin as prophylaxis for COVID-19.
In this study, our objective was to explore the data obtained from the program to evaluate whether the level of regularity of ivermectin use impacted in the reductions in these outcomes, aiming to determine if ivermectin showed a progressive dose-, regularity-response in terms of protection from COVID-19 and COVID-19 related outcomes.
Materials and methods: This is a prospective observational study of the program mention above, that used ivermectin at a dose of 0.2mg/kg/day for two consecutive days, every 15 days. We obtained and analyzed the data regarding the accumulated dose of ivermectin use, in addition to age and co-morbidities, to analyze the patterns of reduction of COVID-19 infection, hospitalization, and mortality rates, and risk of dying from COVID-19, according to the regularity and amount of ivermectin used in a 5-month period.
Following definitions of regularity, we considered as strictly regular subjects that used at least 180mg of ivermectin (180mg = 30 tablets), and as sporadic users subjects that used 60mg (= 10 tablets) or less during the 5-month period.
Comparisons between subjects that did not use ivermectin and these two levels of regularity of ivermectin use were performed. Analysis of the intermediate levels of ivermectin use are present in the supplement appendix of this study. To analyze hospitalization and mortality rates, we utilized the database of COVID-19 infections of all participants, from Itajaí and outside. To analyze COVID-19 infection rate and risk of dying from COVID-19 we utilized the Itajaí city database.
Propensity score matching (PSM) was employed, followed by multivariate adjusted analysis for residual differences (doubly adjusted analysis).
Results:
- Of the 7,345 cases of COVID-19, 3,034 occurred in non-users, 1,627 in sporadic users, and 289 in strict users, while the remaining cases occurred in the intermediate levels of ivermectin use. Strict users were older (p < 0.0001) and non-significant higher prevalence of type 2 diabetes and hypertension.
- COVID-19 infection rate was 39% lower among strict users [4.03% infection rate; ( p < 0.0001] than in non-users (6.64% infection rate), and non-significant 11% reduction compared to sporadic users (4.54% infection rate) (n = 1,627 in each group; RR, 0.89; 95%CI 0.76 – 1.03; p = 0.11).
- Hospitalization rate was reduced by 100% in strict users, compared to non-users and to sporadic users, both before and after Propensity score matching ( p < 0.0001).
- After Propensity score matching, hospitalization rate was 35% lower among sporadic users than non-users (RR, 0.65; 95%CI, 0.44 – 0.70; p = 0.03).
- In propensity score matched groups, multivariate-adjusted mortality rate was 90% lower in strict users compared to non-users (p = 0.003) and 79% lower than in sporadic users (p = 0.05), while sporadic users had a 37% reduction in mortality rate compared to non-users (p = 0.043).
- Risk of dying from COVID-19 was 86% lower among strict users than non-users (p = 0.006) and marginally significant, 72% lower than sporadic users (p = 0.083), while sporadic users had a 51% reduction compared to non-users (p = 0.001).
Conclusion: Non-use of ivermectin was associated with a 10-times increase in mortality risk and 7-times increased risk of dying from COVID-19, compared to strictly regular use of ivermectin in a prospectively collected, strictly controlled population.
A progressive dose-response pattern was observed between level of ivermectin use and level of protection from COVID-19 related outcomes and consistent across different levels of ivermectin use.
The results of this study clearly demonstrate that prophylactic use of ivermectin must be initiated immediately for people in high risk categories in the United States and worldwide. This includes individuals with one or more co-morbidities and the middle aged/elderly. Our “design-to-fail” government funded clinical trials for early treatment and governmental obstructionism regarding life saving treatments to patients must end now.
The CDC chart below for all deaths since the start of the outbreak clearly shows a jump in deaths after 50 years old.
However, as the data for deaths per million per age group is not disclosed, so the age for start of prophylaxis has yet to be determined.
As Omicron has less pathogenicity and slightly different disease profile this too could influence what age prophylaxis treatment should begin. But the data are in, prophylactic use of ivermectin saves lives.
In regards to the table above, the age stratification of disease shows why a universal vaccination program for a vaccine with a high adverse event profile is not advised. It is time to stop all mandates at the Federal and State level. It is time to stop pushing this vaccine on children.
Research and clinical practice show that using re-purposed drugs for Covid-19 have huge benefits. These include multi-drug, multi-staged treatments for Covid-19 disease that prevent severe disease, decreases hospitalization rates and decreases death. It is time our government and state licensing board recognize this and let physicians practice medicine.
‘Off-label’ drug use: an FDA regulatory term, not a negative implication of its medical use. Int J Impot Res. 2008 Mar-Apr;20(2):135-44. doi: 10.1038/sj.ijir.3901619. Epub 2007 Nov 15. PMID: 18004389.
Highlights:
- A doctor’s decision to inform the patient of the ‘off-label’ status of the prescription is not relevant to the physician’s standard of care for an informed consent case.
- The FDA has specifically stated that its procedures and requirements have no effect on the practice of medicine and that the FDA does not prohibit doctors from prescribing drugs in an ‘off-label’ manner.
- The FDA’s approval of a drug is immaterial to the effectiveness in the drug’s ‘off-label’ use. In fact, prescribing medication in an ‘off-label’ manner can constitute the standard of care in many cases.
- A doctor’s duty is to practice medicine and treat his patient, not inform the patient of the FDA’s non-medically related labeling. Therefore, doctors should not be branded with the additional duty of disclosing non-pertinent information, such as the FDA’s medically irrelevant distinction, to their patients
*It is estimated that 21% of all prescription drugs are prescribed “off-label.”
For fun, I took the countries that reportedly use Ivermectin country-wide and compared them to the USA, Israel and Sweden. I chose a three month cut-off, although the results were extended further. I did this because I don’t know when some of the countries began ivermectin use.
Can you guess who now has the highest death rates per million? Yeh –
- USA
- Israel
- Sweden
Notes: I included – India, because although not all regions use Ivermectin – although the most populated due. Likewise Africa – which many nations treat with ivermectin prophylactically and these world maps do not break down Africa by Nations (weirdly imperialistic). I did not include Bulgaria, as although they use ivermectin – their death rate numbers are skewed for other reasons not worth delving into.
There are a lot of confounding variables here. Such as natural immunity, vaccination rates of the elderly and those with co-morbidities, as well as seasonality of the virus, vitamin D3/zinc levels and age of population.
But it is still an interesting snap shot as to where much of the world is right now.
Share this:
Related
February 6, 2022 - Posted by aletho | Science and Pseudo-Science, Timeless or most popular | Covid-19, COVID-19 Vaccine, Ivermectin
No comments yet.
Featured Video
How Many More Gulf States Get Dragged Into Trump’s Iran War?
or go to
Aletho News Archives – Video-Images
Villains of Judea
David Wurmser
A shadowy neocon strategist spent 30 years maneuvering Washington toward war with Iran

José Niño Unfiltered | November 17, 2026
As American forces clash with Iran in 2026, a decades-long campaign orchestrated from the shadows of Washington has finally reached its climax. Earlier this year, foreign policy strategist David Wurmser openly called for Washington to let Israel start a war of aggression against Tehran, portraying the conflict as a historic reckoning akin to the Soviet collapse. For avid critics of American foreign policy, the current war represents the ultimate triumph of a shadowy Jewish operative who spent over 30 years advancing Israeli strategic priorities inside the highest echelons of the United States government.
Born in Switzerland, David Wurmser earned three degrees from Johns Hopkins University, including a doctorate. He spent 11 years in Navy Reserve intelligence and reached the rank of lieutenant commander. During that service, the Defense Intelligence Agency mobilized him for its Iraq Intelligence Task Force in 1994, 1996 and 1998.
Yet his defining partnership was personal as much as institutional. His Israeli born wife, Meyrav Wurmser, wrote her doctoral dissertation on Revisionist Zionism. In 1998, she cofounded the Middle East Media Research Institute, known as MEMRI, with Yigal Carmon, a former colonel in the Israeli military. Carmon served in Israel Defense Forces intelligence from 1968 to 1988. He later advised prime ministers Yitzhak Rabin and Yitzhak Shamir on counterterrorism.
During the mid-1990s, Wurmser moved seamlessly between Washington institutions and Jerusalem policy circles. … continue
Blog Roll
-
Join 2,369 other subscribers
Visits Since December 2009
- 7,826,794 hits
Looking for something?
Archives
Calendar
Categories
Aletho News Civil Liberties Corruption Deception Economics Environmentalism Ethnic Cleansing, Racism, Zionism Fake News False Flag Terrorism Full Spectrum Dominance Illegal Occupation Mainstream Media, Warmongering Malthusian Ideology, Phony Scarcity Militarism Progressive Hypocrite Russophobia Science and Pseudo-Science Solidarity and Activism Subjugation - Torture Supremacism, Social Darwinism Timeless or most popular Video War Crimes Wars for IsraelTags
Afghanistan Africa AIPAC al-Qaeda Australia BBC Benjamin Netanyahu Brazil Canada CDC Central Intelligence Agency China CIA CNN Covid-19 COVID-19 Vaccine Donald Trump Egypt European Union Facebook FBI FDA France Gaza Germany Google Hamas Hebron Hezbollah Hillary Clinton Human rights Hungary India Iran Iraq ISIS Israel Israeli settlement Japan Jerusalem Joe Biden Korea Latin America Lebanon Libya Middle East National Security Agency NATO New York Times North Korea NSA Obama Pakistan Palestine Poland Qatar Russia Sanctions against Iran Saudi Arabia Syria The Guardian Turkiye Twitter UAE UK Ukraine United Nations United States USA Venezuela Washington Post West Bank WHO Yemen Zionism
Aletho News- How Many More Gulf States Get Dragged Into Trump’s Iran War? | Matt Bracken
- US-Iran escalation: The side effects and benefits of low intensity war
- Lebanon on the Brink: How Washington and Tel Aviv Turned the “Peace Process” into an Instrument of Pressure
- Before Laundering The Iran Dirty Bomb Hoax, Jake Tapper Was Israel’s Chief Propagandist For Genocide.
- Minuteman III Test at APEC Opening Aimed to Show US Remains a Dangerous Power – Ex-Pentagon Analyst
- Estonia’s border closure is collective punishment of ethnic Russians
- US Plan to Toughen Restrictions on Chip Exports to China After Nvidia Scandal – Reports
- Villains of Judea: David Wurmser
- Anthony Aguilar: The Point of No Return Has Been Reached
- Iran accuses NYT report of paving way for attacks on dams
If Americans Knew- An error has occurred; the feed is probably down. Try again later.
No Tricks Zone- Argentina’s Perito Moreno Glacier Joins Antarctica and Arctic In Defying Doomsday Melt Claims
- New Study: Barents Sea Temperatures Were Warmer And Sea Ice Less Extensive In The 1700s Than Today
- German Authorities Start Initiative To Evaluate Public Register For Climate “Disinformation” Spreaders!
- Zonal Asymmetry of Temperature Change in the Antarctic Circumpolar Current
- New Study: The Net Fossil Fuel Contribution To Rising Atmospheric CO2 Has Been Zero For 500 Years
- Germany’s Green Energy Transition Becoming Increasingly Expensive…Another 6 Trillion Euros!
- Sudden Stratospheric Warming, Powerful El Niño Combination May Lead To Extreme Europe Cold, Energy Crisis!
- Two New Studies Find Thwaites Glacier Melt Cannot Be Driven By Human Activity Or A Warming Ocean
- E-Cars Reduce CO2 Emissions By Only 41% Compared To Internal Combustion Engine Vehicles
- Predictions Made By Renowned Climate Professor Over Past Decades Have Been Proven To Be Poor
Contact:
atheonews (at) gmail.com
Disclaimer
This site is provided as a research and reference tool. Although we make every reasonable effort to ensure that the information and data provided at this site are useful, accurate, and current, we cannot guarantee that the information and data provided here will be error-free. By using this site, you assume all responsibility for and risk arising from your use of and reliance upon the contents of this site.
This site and the information available through it do not, and are not intended to constitute legal advice. Should you require legal advice, you should consult your own attorney.
Nothing within this site or linked to by this site constitutes investment advice or medical advice.
Materials accessible from or added to this site by third parties, such as comments posted, are strictly the responsibility of the third party who added such materials or made them accessible and we neither endorse nor undertake to control, monitor, edit or assume responsibility for any such third-party material.
The posting of stories, commentaries, reports, documents and links (embedded or otherwise) on this site does not in any way, shape or form, implied or otherwise, necessarily express or suggest endorsement or support of any of such posted material or parts therein.
The word “alleged” is deemed to occur before the word “fraud.” Since the rule of law still applies. To peasants, at least.
Fair Use
This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more info go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
DMCA Contact
This is information for anyone that wishes to challenge our “fair use” of copyrighted material.
If you are a legal copyright holder or a designated agent for such and you believe that content residing on or accessible through our website infringes a copyright and falls outside the boundaries of “Fair Use”, please send a notice of infringement by contacting atheonews@gmail.com.
We will respond and take necessary action immediately.
If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.
All 3rd party material posted on this website is copyright the respective owners / authors. Aletho News makes no claim of copyright on such material.




Leave a Reply